| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO | Director | President &CEO
2 companies
Khattar Jack A. is a President, CEO at SUPN, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 41 sales.
Our model assigns Khattar Jack A. a middling insider score of 64/100, based on 34 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +15.3%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 34,800 | $45.10 | $1,569,430.50 | -3.1% | +2.0% | -3.6% | |
| Aug 25, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 1,000 | $45.00 | $45,000.00 | - | +1.6% | +2.1% | |
| Aug 22, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 1,500 | $45.00 | $67,500.00 | -0.1% | -0.2% | +2.2% | |
| Aug 6, 2025 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE10b5-1 | 140,000 | $42.02 | $5,883,360.00 | -11.6% | +34.3% | +10.2% | |
| Nov 8, 2024 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 125,000 | $36.29 | $4,536,250.00 | -11.9% | +6.1% | +25.7% | |
| Nov 7, 2024 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 125,000 | $36.68 | $4,585,000.00 | -11.9% | +8.5% | +26.4% | |
| Feb 3, 2023 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 13,732 | $42.05 | $577,492.26 | -1.7% | -12.4% | -33.5% | |
| Feb 1, 2023 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 300 | $42.01 | $12,602.01 | - | -10.3% | -33.0% | |
| Jan 31, 2023 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 976 | $42.01 | $41,002.35 | -0.1% | -9.9% | -32.5% | |
| Jan 18, 2023 | SUPN Supernus Pharmaceuticals, Inc. | President, CEO | Sale+OE | 4,936 | $40.40 | $199,394.16 | -0.6% | -9.8% | -31.6% |